[1] FUJII G Y, DE JUAN E, KRAILO M S, et al. Initial experience using the transconjunctival sutureless vitrectomy system for vitreoretinal surgery[J]. Ophthalmology, 2002, 109(10):1814-1820. [2] 李文博, 张玉, 李秋明, 等. 眼底病手术前后干眼调查分析[J]. 中华眼外伤职业眼病杂志, 2019, 41(8):585-592. [3] MESSMER E M. The pathophysiology, diagnosis, and treatment of dry eye disease[J]. Dtsch Arztebl Int, 2015, 112(5):71-81. [4] KOH S, TUNG C I, INOUE Y, et al. Effects of tear film dynamics on quality of vision[J]. Br J Ophthalmol, 2018, 102(12):1615-1620. [5] 邵毅, 吴康瑞, 叶蕾. 干眼的发病机制及治疗研究进展[J]. 眼科新进展, 2020, 40(4):301-306. [6] KATO K, MIYAKE K, HIRANO K, et al. Management of postoperative inflammation and dry eye after cataract surgery[J]. Cornea, 2019, 38(Suppl):S25-S33. [7] 方腾, 李秋明. 玻璃体切割手术联合硅油填充对眼表泪膜稳定性的影响[J]. 中华眼底病杂志, 2018, 34(2):136-138. [8] 王华玲, 赖江龙. 不同表面麻醉剂在眼科A超检查中对角膜上皮的损伤研究[J]. 国际眼科杂志, 2014, 14(11):2062-2063. [9] HESSEN M, AKPEK E K. Dry eye: an inflammatory ocular disease[J]. J Ophthalmic Vis Res, 2014, 9(2):240-250. [10] SITOMPUL R, SANCOYO G S, HUTAURUK J A, et al. Sensitivity change in cornea and tear layer due to incision difference on cataract surgery with either manual small-incision cataract surgery or phacoemulsification[J]. Cornea, 2008, 27(Suppl 1): S13-S18. [11] ABLAMOWICZ A F, NICHOLS J J. Ocular surface membrane-associated mucins[J]. Ocul Surf, 2016, 14(3):331-341. [12] MCCABE E, NARAYANAN S. Advancements in anti-inflammatory therapy for dry eye syndrome[J]. Optometry, 2009, 80(10): 555-566. [13] 朱研. 局部药物中不同防腐剂对青光眼患者干眼的影响差异[J]. 中国眼耳鼻喉科杂志, 2016, 16(6):402-405. [14] 贺翔鸽. 重视长期局部应用抗青光眼药物对眼表组织的损伤[J]. 中华眼科杂志, 2011, 47(2):101-104. [15] CHO Y K, KIM M S. Dry eye after cataract surgery and associated intraoperative risk factors[J]. Korean J Ophthalmol, 2009, 23(2):65-73. [16] 宁琳, 孔珺, 张劲松. 角膜散光对干眼患者泪膜的影响[J]. 眼科新进展, 2008, 28(11):860-862. [17] VICTORIA A C, CHUCK R S, ROSENBERG J B, et al. Timing of eyelid surgery in the setting of refractive surgery: preoperative and postoperative considerations[J]. Curr Opin Ophthalmol, 2011, 22(4): 226-232. |